Financial Statements

Vaxart Inc

Vaxart Inc (VXRT)

$7.4
0.51 (+7.40%)

Income Statement

Quarter Data

Balance Sheet Statement

Quarter Data
Year 2019 2018 2017 2016 2015 2014 2013 2011 2010 2009 2008
Short-term debt -6.00---------
Other Assets 11.100.800.70-1.500.90---0.100.14
Total current liabilities 7.6033.9017.906.3017.6026.909.009.204.527.479.17
Cash and cash equivalents 106.4059.5053.6094.3066.8081.7044.7049.701.5711.5113.53
Long-term debt 15.20-----0.800.3038.721.94-
Cash and short-term investments 130.30119.00108.2096.4066.8081.7057.6069.002.9911.5113.53
Total debt 15.206.00----1.000.7040.253.61-
Inventories -----------
Deferred revenue -18.457.802.530.30--1.30-3.33-
Goodwill and Intangible Assets ----0.60---0.0419.4117.09
Total non-current liabilities 15.20-35.4032.800.200.200.9017.3038.7216.5114.91
Total non-current assets 2.001.603.900.105.8012.908.600.300.7720.5819.43
Total liabilities 22.8033.9053.3039.1017.8027.109.9026.5043.2423.9924.08
Total assets 144.20131.30113.9098.0085.80114.0079.4072.704.5235.2337.03
Other comprehensive income 0.10---25.3026.80-19.00---
Short-term investments 23.9059.5054.602.10--12.9019.301.42--
Property, Plant & Equipment Net 1.300.900.600.104.302.000.200.300.731.072.20
Net Debt -91.20-53.50-53.60-94.30-66.80-81.70-43.70-49.0038.68-7.89-13.53
Investments 23.9059.5057.102.10-10.0012.9019.301.42--
Total shareholders equity 121.4097.4060.6058.9068.0086.9069.5046.20-38.7211.2412.95
Retained earnings (deficit) -205.70-224.40-223.50-228.10-78.80-89.80-108.90-134.30-79.98-97.99-116.66
Long-term investments --2.50--10.00-----
Receivables -9.101.001.0011.0018.7012.600.700.631.803.62
Payables 1.201.700.600.102.402.801.903.901.390.960.85
Total current assets 142.20129.70110.0097.9080.00101.1070.8072.403.7514.6417.60

Cash Flow Statement

Quarter Data
Year 2019 2018 2017 2016 2015 2014 2013 2011 2010 2009 2008
Operating Cash Flow -18.906.2239.93-15.17-13.90-3.30-9.60-14.10-10.04-14.55-13.09
Free Cash Flow -18.956.2239.78-15.17-14.90-3.40-9.70-14.30-10.16-15.26-13.94
Capital Expenditure -0.05--0.15--1.00-0.10-0.10-0.20-0.12-0.71-0.85
Depreciation & Amortization 0.570.500.380.243.002.401.100.100.383.203.60
Acquisitions and disposals -------8.90----
Deferred income taxes ----1.50------
Investment purchases -23.87-91.47-140.29-11.60--10.00-17.70-15.30--0.57-
Accounts payables -4.982.301.71-5.862.8010.60-15.80-0.700.01-3.78-0.06
Sales/Maturities of investments -55.83142.6966.62-------
Change in working capital -4.2311.3535.27-12.54-4.503.60-11.509.10-0.622.451.28
Debt repayment ----------0.21-3.80
Other non-cash items 7.7413.103.414.65-5.001.7019.902.10-0.21-2.190.68
Investing Cash Flow -20.65-35.642.3055.2531.70-10.10-19.401.303.1826.21-0.85
Cash at beginning of period 217.60106.4059.5053.6094.3066.8081.7044.7017.701.5711.51
Stock-based compensation 2.732.463.922.172.601.702.102.00-0.540.63
Net cash flow / Change in cash -111.17-46.93-5.9540.7513.0014.90-37.005.00-6.839.942.02
Effect of forex changes on cash -----4.801.50-----
Financing Cash Flow -71.62-17.50-48.180.66-26.80-0.1017.800.02-1.7315.96
Dividend payments -----------
Accounts receivables --6.688.090.04-4.20-7.106.2011.90-0.0313.50-1.82
Cash at end of period 106.4359.4753.5594.35107.3081.7044.7049.7010.8711.5113.53
Net cash provided by operating activities -18.906.2239.93-15.17-13.90-3.30-9.60-14.10-10.04-14.55-13.09
Other working capital 134.5495.7892.0991.6375.3098.3061.8063.20-7.178.42
Inventory -----------

Retained Earning Schedule

Year 2008 2009 2010 2011 2013 2014 2015 2016 2017 2018 2019
Retained Earnings (Previous Year) -170-206-224-224--79-90-109-134-80-98
Net Income -19-191-5-9-11-19-25-10-18-19
Stock Dividends -17---0-70---64--0
Dividend Paid -----------
Retained Earnings -206-224-224-228-79-90-109-134-80-98-117

PPE Schedule

Year 2008 2009 2010 2011 2013 2014 2015 2016 2017 2018 2019
Gross PPE 2111-420011
Annual Depreciation -1-0-0-15-2-20112
Capital Expenditure -0--0--1-0-0-0-0-1-1
Net PPE 11104200112

Intangible and Goodwill Schedule

Year 2008 2009 2010 2011 2013 2014 2015 2016 2017 2018 2019
Intangible and Goodwill (Previous Year) -----1---019
New Purchases -24-91-140-12--10-18-15--1-
Intangible and Goodwill ----1---01917

Vaxart Inc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Vaxart Inc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.